BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 26
• 27
• 28
• 29
• 30

• BioMidwest

  Baxter International, Inc.’s Commitment to Incorporating Sustainable Practices Into Business Recognized by Leading Organizations

  November 5, 2012

   · 

  1 min read
• Biotech Bay

  ReCor Medical Reports 100% Responder Rate at One-Year Follow-up in Clinical Trial of Its Ultrasound-Based PARADISE™ Renal Denervation System for Treating Resistant Hypertension, a Major Risk Factor for Cardiovascular Disease

  November 5, 2012

   · 

  1 min read
• Business

  PsychoGenics Inc. Achieves Substantial Milestone in Its Drug Discovery Collaboration With Sunovion Pharmaceuticals Inc.

  November 5, 2012

   · 

  1 min read
• BioCapital

  Incyte Corporation to Present at the Jefferies and Co. 2012 Global Healthcare Conference (London)

  November 5, 2012

   · 

  1 min read
• Policy

  FDA Designates Durata Therapeutics, Inc. ' Dalbavancin a Qualified Infectious Disease Product (QIDP)

  November 5, 2012

   · 

  1 min read
• Genetown

  Celldex Therapeutics, Inc. Announces Upcoming Data Presentations at the Society for Neuro-Oncology 17th Annual Scientific Meeting and Education Day

  November 5, 2012

   · 

  1 min read
• Drug Development

  Boehringer Ingelheim GmbH Release: FDA and FDA Reaffirm Important Health Benefits and Safety of Pradaxa® (dabigatran etexilate) for Patients With Atrial Fibrillation

  November 5, 2012

   · 

  1 min read
• Drug Development

  FibroGen, Inc. Announces Results Showing That FG-4592, An Oral Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor (HIF-PHI), Corrects Anemia Without Intravenous Iron Supplementation in Incident Dialysis Patients

  November 5, 2012

   · 

  1 min read
• Business

  BioLineRx Ltd. to Report Third Quarter 2012 Results on November 14, 2012

  November 5, 2012

   · 

  1 min read
• Business

  Daiichi Sankyo, Inc. CEO John Gargiulo Elected as National Pharmaceutical Council’s Chairman of the Board

  November 5, 2012

   · 

  2 min read